Demonstrates that targeting VGICs improves prognosis in papillary thyroid carcinoma, suggesting new treatment possibilities.
Specific VGIC gene signatures provide powerful prognostic biomarkers in PTC. Beyond improving prognosis, targeting these VGICs-especially ATP2C2-offers a novel approach to reshape the tumor metabolic microenvironment and inhibit PTC progression.
No takes yet. Share an insight, caveat, or question.
Sun et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: